|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 198.99 USD | -1.86% |
|
-2.39% | -17.39% |
| 07-17 | RBC Downgrades ResMed to Sector Perform From Outperform, Cuts Price Target to $234 From $276 | MT |
| 07-15 | Mizuho Adjusts Price Target on ResMed to $220 From $235, Maintains Outperform Rating | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 219.75 | 230.7 | 233.52 |
| Spread/Res. | -9.45% | -13.75% | -14.79% |
| Spread/Supp. | +8.84% | +8.84% | +5.49% |
| Support | 182.82 | 182.82 | 188.63 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- RMD Stock
- Charts ResMed, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
